Loading
Life sciences · Journal article
Journal of Clinical Medicine · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Obesity is a heterogeneous condition encompassing metabolically healthy and metabolically unhealthy phenotypes. Routine liver enzymes may reflect metabolic heterogeneity among individuals with obesity, yet their metabolic relevance in non-diabetic obesity remains incompletely characterized, particularly in Arab populations. This study examined the associations of routine liver enzymes with obesity severity and metabolic abnormalities in Saudi adults with non-diabetic obesity. Methods: This cross-sectional study included 168 non-diabetic adults with obesity. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), and alkaline phosphatase (ALP) were evaluated in relation to obesity severity, prediabetes, hypercholesterolemia, hypertriglyceridemia and metabolic syndrome (MetS). Correlation, multivariable linear regression, and receiver operating characteristic (ROC) analyses were performed to examine associations with obesity severity, prediabetes, hypercholesterolemia, and hypertriglyceridemia. Results: ALT, AST, and GGT generally increased with obesity severity, with ALT and GGT significantly higher in Class III than Class I obesity. GGT showed the most consistent differences across metabolic abnormalities, with higher concentrations in participants with prediabetes (20.0 vs. 16.0 U/L), hypercholesterolemia (21.0 vs. 16.0 U/L), and hypertriglyceridemia (22.0 vs. 17.0 U/L). GGT was also higher in participants with MetS (20.0 vs. 16.0 U/L). After multivariable adjustment, GGT remained positively associated with HbA1c (β = 0.031) and triglycerides (β = 0.188), while ALT was associated with BMI (β = 0.04). ROC analyses showed modest, outcome-specific discrimination, with GGT showing the highest discrimination for hypertriglyceridemia (AUC = 0.68). Conclusions: Liver enzyme profiles, particularly GGT and ALT, are associated with distinct dimensions of metabolic dysfunction in non-diabetic adults with obesity. GGT demonstrated the most consistent metabolic relationships with glycemic and lipid abnormalities, although the modest discriminatory performance supports its potential role as a complementary rather than standalone metabolic indicator.